GBA1 and Parkinson disease: From a clinical perspective, PD patients harboring GBA1 mutations typically present with early onset of the disease, experience more rapid progression of motor impairment and cognitive decline, and have reduced survival rates2, suggesting that GCase plays a central role in the pathophysiology.